Product Information
GNP CHILD CGH RLF 5-100 MG/5 ML is a generic product labeled by AmerisourceBergen, priced at $0.0235 per ML under NDC 46122078629. Its NADAC has been published 74 times since May 7, 2025.
Strength
5; 100 mg/5mL; mg/5mL
Manufacturer
AmerisourceBergenNDC
46122078629
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/24/2024
Pharmacological Classes
Price Statistics
The NADAC for GNP CHILD CGH RLF 5-100 MG/5 ML has been published 74 times since May 7, 2025, and over the history we have for it it has risen 27.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0235 per ML |
|---|---|
| All-time high | $0.0237 (Sep 16, 2026) |
| All-time low | $0.0185 (May 7, 2025) |
| 52-week high | $0.0237 |
| 52-week low | $0.0210 |
| Median price | $0.0216 |
| Average price | $0.0214 |
| Largest weekly change | +4.6% (Aug 20, 2025) |
| Weeks tracked | 74 |
| Tracking since | May 7, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP CHILD CGH RLF 5-100 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for GNP CHILD CGH RLF 5-100 MG/5 ML, manufactured by AmerisourceBergen, is $0.0235 per ML (NDC 46122078629), effective Sep 30, 2026.
How has the price of GNP CHILD CGH RLF 5-100 MG/5 ML changed over time?
Over the history we have for it, the NADAC for GNP CHILD CGH RLF 5-100 MG/5 ML has risen 27.0%. It has been tracked across 74 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for GNP CHILD CGH RLF 5-100 MG/5 ML?
Since May 7, 2025, the NADAC for GNP CHILD CGH RLF 5-100 MG/5 ML has ranged from a low of $0.0185 (May 7, 2025) to a high of $0.0237 (Sep 16, 2026), with a median of $0.0216 per ML.
Are there cheaper alternatives to GNP CHILD CGH RLF 5-100 MG/5 ML?
No other NADAC-published product currently shares the active ingredient and strength of GNP CHILD CGH RLF 5-100 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GNP CHILD CGH RLF 5-100 MG/5 ML?
GNP CHILD CGH RLF 5-100 MG/5 ML (NDC 46122078629) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.